This last hypothesis still needs to be experimentally probed, but it seems clear that the GPR37/A2AR heteromer, which here we demonstrate is formed in native conditions, may constitute a novel and very attractive target for the design of new pharmacological strategies to manage pathologies affecting dopaminergic neurotransmission such as PD. The gene discussed is GPR37; the disease is Parkinson disease.